Worried About CTE? What to Know About Risk, Symptoms, and Diagnosis
You may have heard about chronic traumatic encephalopathy (CTE), a brain disease linked to repeated hits to the head. CTE has been found in some former NFL players and others who had repeated head impacts. If you or a family member played contact sports, you may...
What to Know About mFlusiva, the New mRNA Flu Vaccine
For the first time, adults age 50 and older in the United States can get an mRNA flu vaccine. The U.S. Food and Drug Administration (FDA) approved mFlusiva®, the first mRNA flu vaccine, in August 2026. Moderna makes mFlusiva. It uses the same basic vaccine technology...
U.S. Premiere for Opera on a Gender-Affirmation Pioneer Is Authored by Mount Sinai Neuroradiologist
“It’s a love story,” says Aryeh Lev Stollman, MD, a neuroradiologist at Mount Sinai and the librettist for the opera, Lili Elbe, which tells the story of one of the earliest recipients of gender-affirming surgery in 1930. The groundbreaking opera had its U.S. premiere...
How Much Do You Know About Prostate Cancer? Take the Quiz
Prostate cancer is one of the most common cancers among men, affecting about one in eight men in their lifetime. Knowing the facts about prostate cancer can help reduce your risk. Take the quiz below, then click “Done” to see your score and correct answers. This quiz...
This Master of Public Health Student Is on a Mission to Prevent Diabetes and Obesity Through Nutrition Education
Ayannah Riley, MPH, earned her Master of Public Health degree from the Icahn School of Medicine at Mount Sinai in 2026, with a concentration in Health Promotion and Disease Prevention. With a background in nutrition, exercise science, fitness, and community health,...
Who Is at Risk of Postpartum Psychosis—and Is It Treatable?
Having a baby can turn your world upside down. Many new mothers experience a feeling of sadness that may last for a few weeks and go away on its own. And about one in eight women reported signs of a more significant postpartum depression, according to the Centers for...
GLP-1 Medications Explained: What You Should Know
GLP-1 medications are now a major topic in health care and the news. These drugs can help people manage type 2 diabetes and lose weight. Researchers are also studying how they may help with other health problems. What are GLP-1 medications? How do they work? What...
Can GLP-1 Receptor Agonists Help Preserve Brain Volume?
For those living with multiple sclerosis (MS), GLP-1 receptor agonists (GLP-1 RA) might represent a new mechanism for combating disease progression. Though initially developed for diabetes treatment, GLP-1 agents have become famous for inducing weight loss. However,...
This Research Scientist Has Lived With MS for 20 Years. Here’s How He Has Remained Hopeful and Productive
Scott Mellis, MD, PhD, has lived with secondary progressive multiple sclerosis (MS) for more than 20 years under the care of doctors at The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. It has not always been easy. He has one message for...